UCLouvain spin-off, BiocSol which specialises in sustainable crop protection solutions recently announced the successful closure of its initial seed funding round after securing US$5.6mn in equity
BiocSol aims to attract a total US$10.5mn by year-end through additional non-dilutive and equity financing. Agri Investment Fund and VIVES IUF led the round, bringing extensive expertise in agribusiness and biotechnology, alongside Belgian investors, including Invest.BW and IMBC Spinnova SA.
The funding, which behaves as a catalyst for BiocSol's development, will not only enable the company to broaden its team and R&D pipeline, but also kickstart the regulatory processes for its pioneering biofungicies. Moreover, the product will also increase production to meet demand and optimise its quality and efficiency processes. BiocSol empowers farmers through the development of innovative microbial-based biopesticies, thereby providing an efficient biocontrol to protect their crops.
“This new investment is strategic for our fund as it enables us to become part of the rapidly growing Wallonia AgTech ecosystem,” said Patrik Haesen, CEO of Agri Investment Fund. “We are particularly impressed by BiocSol's innovative approach, which addresses some of the most pressing agricultural problems by creating multiple modes of action to combat pathogens that are swiftly developing resistance to current solutions.”
Advancing their mission to develop sustainable crop protection solutions, CTO and founder of BiocSol, Simon Caulier emphasised that they were at a pivotal moment for the company. "This investment allows us to bring impactful solutions to agriculture, fostering a healthier planet for future generations,” Caulier concluded.